254 related articles for article (PubMed ID: 34468254)
21. MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction.
Ding YQ; Zhang YH; Lu J; Li B; Yu WJ; Yue ZB; Hu YH; Wang PX; Li JY; Cai SD; Ye JT; Liu PQ
Acta Pharmacol Sin; 2021 Sep; 42(9):1422-1436. PubMed ID: 33247214
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of lncRNA Gm15834 Attenuates Autophagy-Mediated Myocardial Hypertrophy via the miR-30b-3p/ULK1 Axis in Mice.
Song C; Qi H; Liu Y; Chen Y; Shi P; Zhang S; Ren J; Wang L; Cao Y; Sun H
Mol Ther; 2021 Mar; 29(3):1120-1137. PubMed ID: 33130312
[TBL] [Abstract][Full Text] [Related]
23. Circ_0001742 promotes tongue squamous cell carcinoma progression via miR-431-5p/ATF3 axis.
Hu YT; Li XX; Zeng LW
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10300-10312. PubMed ID: 31841185
[TBL] [Abstract][Full Text] [Related]
24. MiR-423-5p Inhibition Exerts Protective Effects on Angiotensin II-Induced Cardiomyocyte Hypertrophy.
Xu M; Liu D; Gao X; Wang Z; Zhang L; Fan H
Tohoku J Exp Med; 2023 Feb; 259(3):199-208. PubMed ID: 36517015
[TBL] [Abstract][Full Text] [Related]
25. Circ-SIRT1 inhibits cardiac hypertrophy via activating SIRT1 to promote autophagy.
Wang W; Wang L; Yang M; Wu C; Lan R; Wang W; Li Y
Cell Death Dis; 2021 Nov; 12(11):1069. PubMed ID: 34759275
[TBL] [Abstract][Full Text] [Related]
26. A new miRNA regulator, miR-672, reduces cardiac hypertrophy by inhibiting JUN expression.
Lu Y; Wu F
Gene; 2018 Mar; 648():21-30. PubMed ID: 29339068
[TBL] [Abstract][Full Text] [Related]
27. Silencing of circCacna1c Inhibits ISO-Induced Cardiac Hypertrophy through miR-29b-2-5p/NFATc1 Axis.
Lu P; Zhang D; Ding F; Ma J; Xiang YK; Zhao M
Cells; 2023 Jun; 12(12):. PubMed ID: 37371137
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of SNHG16 induced by CTCF accelerates cardiac hypertrophy by targeting miR-182-5p/IGF1 axis.
Wang D; Lin B; Zhang W; Wang X
Cell Biol Int; 2020 Jul; 44(7):1426-1435. PubMed ID: 32125046
[TBL] [Abstract][Full Text] [Related]
29. Circ-Zfp644 acts as a pro-hypertrophic mediator in an Ang-II induced in vitro myocardial hypertrophy model.
Chen Y; Song D; Gao J; Zhang X; Chen X
Cell Biol Int; 2021 Jun; 45(6):1260-1268. PubMed ID: 33559936
[TBL] [Abstract][Full Text] [Related]
30. MiR-378 Inhibits Angiotensin II-Induced Cardiomyocyte Hypertrophy by Targeting AKT2.
Wang G; Feng L; Liu C; Han Z; Chen X
Int Heart J; 2024; 65(3):528-536. PubMed ID: 38825497
[TBL] [Abstract][Full Text] [Related]
31. MiR-195-5p Promotes Cardiomyocyte Hypertrophy by Targeting MFN2 and FBXW7.
Wang L; Qin D; Shi H; Zhang Y; Li H; Han Q
Biomed Res Int; 2019; 2019():1580982. PubMed ID: 31341888
[TBL] [Abstract][Full Text] [Related]
32. The long noncoding RNA XIST regulates cardiac hypertrophy by targeting miR-101.
Xiao L; Gu Y; Sun Y; Chen J; Wang X; Zhang Y; Gao L; Li L
J Cell Physiol; 2019 Aug; 234(8):13680-13692. PubMed ID: 30605239
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-375-3p inhibitor suppresses angiotensin II-induced cardiomyocyte hypertrophy by promoting lactate dehydrogenase B expression.
Feng H; Wu J; Chen P; Wang J; Deng Y; Zhu G; Xian J; Huang L; Ouyang W
J Cell Physiol; 2019 Aug; 234(8):14198-14209. PubMed ID: 30618075
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
[TBL] [Abstract][Full Text] [Related]
35. STAT3-induced upregulation of lncRNA MEG3 regulates the growth of cardiac hypertrophy through miR-361-5p/HDAC9 axis.
Zhang J; Liang Y; Huang X; Guo X; Liu Y; Zhong J; Yuan J
Sci Rep; 2019 Jan; 9(1):460. PubMed ID: 30679521
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-19a/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5A.
Liu K; Hao Q; Wei J; Li GH; Wu Y; Zhao YF
J Hypertens; 2018 Sep; 36(9):1847-1857. PubMed ID: 29664809
[TBL] [Abstract][Full Text] [Related]
37. The cardiac maladaptive ATF3-dependent cross-talk between cardiomyocytes and macrophages is mediated by the IFNγ-CXCL10-CXCR3 axis.
Koren L; Barash U; Zohar Y; Karin N; Aronheim A
Int J Cardiol; 2017 Feb; 228():394-400. PubMed ID: 27870968
[TBL] [Abstract][Full Text] [Related]
38. Activating transcription factor 3 deficiency promotes cardiac hypertrophy, dysfunction, and fibrosis induced by pressure overload.
Zhou H; Shen DF; Bian ZY; Zong J; Deng W; Zhang Y; Guo YY; Li H; Tang QZ
PLoS One; 2011; 6(10):e26744. PubMed ID: 22053207
[TBL] [Abstract][Full Text] [Related]
39. Circular RNA-circPan3 attenuates cardiac hypertrophy via miR-320-3p/HSP20 axis.
Fang X; Ao X; Xiao D; Wang Y; Jia Y; Wang P; Li M; Wang J
Cell Mol Biol Lett; 2024 Jan; 29(1):3. PubMed ID: 38172650
[TBL] [Abstract][Full Text] [Related]
40. miR-200a-5p augments cardiomyocyte hypertrophy induced by glucose metabolism disorder via the regulation of selenoproteins.
Yang T; Liu T; Cao C; Xu S
J Cell Physiol; 2019 Apr; 234(4):4095-4103. PubMed ID: 30144391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
